4th European Live Summit on Retrograde CTO Revascularization May 8 – 9, 2015 Congress Venue: University Heart Center Zurich University Hospital Zurich, Switzerland University of Catania – Italy University of Thessaloniki – Greece University of Zurich – Switzerland Foto: Jan Lipton Alfredo R. Galassi MD, FACC, FESC, FSCAI Thomas F. Lüscher MD, FACC, FESC George Sianos MD, PhD, FESC
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
4th European Live Summit onRetrograde CTO RevascularizationMay 8–9, 2015
Congress Venue: University Heart Center ZurichUniversity Hospital Zurich, Switzerland
University of Catania – Italy University of Thessaloniki – GreeceUniversity of Zurich – Switzerland
Foto: Jan Lipton
Alfredo R. Galassi MD, FACC, FESC, FSCAI Thomas F. Lüscher MD, FACC, FESC George Sianos MD, PhD, FESC
COURSE DIRECTORSAlfredo R. Galassi MD, FACC, FESC, FSCAIUniversity of Catania, Italy
Thomas F. Luescher MD, FACC, FESCUniversity Hospital Zurich, Switzerland
George Sianos MD, PhD, FESCAHEPA University Hospital Thessaloniki, Greece
4th European Live Summit on
Retrograde CTO RevascularizationMay 8–9, 2015
COURSE CO-DIRECTORSAlexandre Avran MDClinique Generale de Marignane et Hopital privéClairval Marignane et Marseille, France
Carlo Di Mario MD, PhD, FACC, FESCBrompton Hospital, London, England
Javier Escaned MD, PhD, FESCSan Carlo Hospital, Madrid, Spain
Oliver Gaemperli MDUniversity Hospital Zurich, Switzerland
Evald Høj Christiansen MDAarhus University Hospital, Denmark
Nicolaus Reifart MD, PhD, FACC, FESCMain Taunus Kliniken, Bad Soden, Germany
Daniel Weilenmann MD, FESC, FSCAIKantonsspital St. Gallen, Switzerland
Gerald S Werner MD PhD, FACC FESCKlinikum Darmstadt, Germany
INTERNATIONAL FACULTY
William Lombardi, USADimitrios Karmpaliotis, USAStephane Rinfret, CanadaOsamu Katoh, JapanMasahisa Yamane, Japan
INVITED FACULTY (to be confirmed)
Chris Zambakides, South AfricaMeruzhan Saghatelyan, ArmeniaKhaled Shokry, EgyptSatoru Sumitsuji, JapanBradley Strauss, CanadaPatrick Siegrist, Japan
Chronic total occlusion (CTO) recanalization in addition to anginaand dyspnea relief, may provideadditional benefits, including avoidance of bypass surgery and enhanced quality of life and survival.To achieve such clinical benefits, the procedure has to be technically successful, and complicationsmust be avoided.
Retrograde CTO percutaneous coronary intervention was first mastered by Japanese operators,which opened new perspectives through the use of small collateral branches. The technique hasevolved rapidly, resulting in shortened procedural time and reduced radiation, compared with theearlier days. Therefore, the knowledge and expertise in the retrograde techniques have become an essential adjunct for CTO operators to improve procedural success rate.
After the success of the first three meetings, we decided to renew this appointment with the aim to focus on the progress of retrograde strategies faced during last year.
As for previous years, the Summit is primarily based on live cases, lectures as well as interactive sessions on recorded cases, during which key opinion-leaders will discuss on different techniquesand strategies.
This Summit represents a unique opportunity for meeting experts, allowing open discussions on hot issues, challenging treatments and new therapeutic answers in a friendly environment.We look forward to welcoming you.
With best regards
Alfredo R. Galassi George Sianos Thomas F. Luescher
4th European Live Summit on
Retrograde CTO RevascularizationMay 8–9, 2015
TOPICS
– New guidewires for retrograde approach: core concepts and new technology
– The retrograde approach: when as first line strategy and pure retrograde crossing
– The retrograde approach: when as an hybrid approach
– Is CT scan really helpful for long and complex lesions to be approached retrogradely?
– European experience of the retrograde approach
– Complex retrograde PCI: tips and tricks
– Management of complications with retrograde approach
Luncheon panels:
– Complication cases
– Strategy in CTOs: The role of new stents and bioresorbable vascular scaffolds